CL2012001995A1 - Composicion oral de un agente inmunogénico; metodo para preparar dicha compposicion; metodo de vacunación o de reforzamiento por via oral de un animal contra un patógeno - Google Patents

Composicion oral de un agente inmunogénico; metodo para preparar dicha compposicion; metodo de vacunación o de reforzamiento por via oral de un animal contra un patógeno

Info

Publication number
CL2012001995A1
CL2012001995A1 CL2012001995A CL2012001995A CL2012001995A1 CL 2012001995 A1 CL2012001995 A1 CL 2012001995A1 CL 2012001995 A CL2012001995 A CL 2012001995A CL 2012001995 A CL2012001995 A CL 2012001995A CL 2012001995 A1 CL2012001995 A1 CL 2012001995A1
Authority
CL
Chile
Prior art keywords
composition
oral
vaccination
pathogen
preparing
Prior art date
Application number
CL2012001995A
Other languages
English (en)
Inventor
Moti Harel
Brian Carperter
Original Assignee
Advanced Bionutrition Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46514232&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012001995(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/466,279 external-priority patent/US8778384B2/en
Application filed by Advanced Bionutrition Corp filed Critical Advanced Bionutrition Corp
Publication of CL2012001995A1 publication Critical patent/CL2012001995A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

Composición oral de un agente inmunogénico; método para preparar dicha composición; método de vacunación o de reforzamiento por vía oral de un animal contra un patógeno.
CL2012001995A 2012-05-08 2012-07-18 Composicion oral de un agente inmunogénico; metodo para preparar dicha compposicion; metodo de vacunación o de reforzamiento por via oral de un animal contra un patógeno CL2012001995A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/466,279 US8778384B2 (en) 2008-03-24 2012-05-08 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals

Publications (1)

Publication Number Publication Date
CL2012001995A1 true CL2012001995A1 (es) 2012-12-14

Family

ID=46514232

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2012001995A CL2012001995A1 (es) 2012-05-08 2012-07-18 Composicion oral de un agente inmunogénico; metodo para preparar dicha compposicion; metodo de vacunación o de reforzamiento por via oral de un animal contra un patógeno
CL2015003104A CL2015003104A1 (es) 2012-05-08 2015-10-21 Composiciones y métodos para encapsular vacunas para vacunación oral y vacunación de refuerzo en peces y otros animales

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2015003104A CL2015003104A1 (es) 2012-05-08 2015-10-21 Composiciones y métodos para encapsular vacunas para vacunación oral y vacunación de refuerzo en peces y otros animales

Country Status (5)

Country Link
EP (1) EP2662074B1 (es)
CA (1) CA2783146C (es)
CL (2) CL2012001995A1 (es)
DK (1) DK2662074T3 (es)
ES (1) ES2693539T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2015002907A1 (es) * 2015-09-29 2016-06-17 Univ Santiago Chile Vacuna oral contra isav que comprende nanopartículas de quitosán que encapsulan una virina del virus isa y nanoparticulas de quitosán que encapsulan un adyuvante que consiste en un adn que se codifica para la replicasa/transcriptasa de un alfavirus de salmón (replicón), proceso de preparación, método para tratar peces infectados con isav y método para estimular la respuesta inmune en peces.
JP6992057B2 (ja) 2016-06-10 2022-01-13 クラリティ コスメティックス インコーポレイテッド 非面皰形成性の毛髪および頭皮ケア製剤ならびにその使用方法
JP7146788B2 (ja) 2017-02-28 2022-10-04 ルメント アーベー 腹部ｃｔ用経口陰性造影剤
CN109172817B (zh) * 2018-08-16 2021-10-26 华中农业大学 猪流行性腹泻病毒减毒活疫苗壳聚糖微球的制备方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7998502B2 (en) * 2008-03-24 2011-08-16 Advanced Bionutrition Corp. Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
EP2410996B1 (en) * 2009-03-27 2017-08-02 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish

Also Published As

Publication number Publication date
EP2662074B1 (en) 2018-09-26
CA2783146A1 (en) 2013-11-08
CA2783146C (en) 2020-04-07
DK2662074T3 (en) 2018-12-10
ES2693539T3 (es) 2018-12-12
EP2662074A1 (en) 2013-11-13
CL2015003104A1 (es) 2016-06-24

Similar Documents

Publication Publication Date Title
IL240488A0 (en) Vaccine preparation for mers corona virus infection
CR20130613A (es) Herramienta dental y dispositivos de guía
BR112013010288A2 (pt) método de produção de uma vacina para proteger um animal de biótipo de microrganismo, vacina para proteger um animal de um biótipo de microrganismo, método para proteger um animal e método para determinar se um animal foi vacinado
CO6331297A2 (es) Composiciones adyuvantes novedosas
MX2017001406A (es) Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva.
BR112014025726A2 (pt) mecanismo, sistema e método para tratamento endodôntico
BR112013019702A2 (pt) composições dentais compreendendo agente de adição-fragmentação etilenicamente insaturado.
MX2017012220A (es) Composiciones adyuvantes y metodos relacionados.
CO6751260A2 (es) Vacunas basadas en omv contra infecciones por burkholderia
BR112013030321A2 (pt) composição de vacina, método para preparar a composição de vacina, uso da composição de vacina, método para imunizar um porco, cepa de vacina contra csfv e uso de uma célula no cultivo de uma cepa de vacina contra csfv.
MX349119B (es) Vacuna de virus de dengue inactivado.
CL2015001772A1 (es) Composición farmacéutica para el tratamiento de dolor cabeza, y método de preparación de la misma.
CL2015001562A1 (es) Método para obtener una vacuna de mycoplasma.
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
PE20140255A1 (es) Tableta dispersable en forma oral
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
CL2014001719A1 (es) Metodo para tratar la perdida osea alveolar que comprende anticuerpo antiesclerostina.
BR112013031760A2 (pt) vacina contra coronavírus canino
BR112013029514A2 (pt) composição imunogênica, vacina, e, método de tratar ou impedir uma doença
MX2016010838A (es) Vacunas de proproteina convertasa subtilisina/kexina tipo 9 (pcsk9).
EP3541419A4 (en) IMMUNOGENIC COMPOSITION FOR MERS CORONAVIRUS INFECTION
CL2012001995A1 (es) Composicion oral de un agente inmunogénico; metodo para preparar dicha compposicion; metodo de vacunación o de reforzamiento por via oral de un animal contra un patógeno
IN2014DN03464A (es)
UY34286A (es) Diagnóstico de vacuna mejorado
ITTO20120461A1 (it) Agente per il controllo di ectoparassiti di animali.